Finally, CISD1, ATP5MC3, PGD, SLC7A11, ACSL3, and FANCD2 expression was confirmed to significantly correlate with tumor mutational burden (TMB), microsatellite instability (MSI), immune cell infiltration, cellular checkpoint dysfunction, and cancer sensitivity to drugs. The gene discussed is ACSL3; the disease is neoplasm.